Launching in November | New patients: 30% off your first 3 months. Veterans: 30% off for life. |
Launching in November | New patients: 30% off your first 3 months. Veterans: 30% off for life. |
A peptide therapy that works through the brain’s arousal pathways rather than blood flow alone — for men and women navigating low libido.
PT-141 (bremelanotide) is a melanocortin receptor agonist that acts on the central nervous system to increase sexual desire, distinguishing it from PDE5 inhibitors that work only on blood flow. It’s prescribed for both men and women experiencing low libido.
TYPICAL SUBCUTANEOUS DOSE
TYPICAL DOSING, BEFORE INTIMACY
ONSET OF EFFECT
Works on arousal pathways in the brain, not just blood flow.
Can be paired with PDE5 inhibitors for members where desire and blood flow are both factors.
One of few options clinically used across both sexes for low libido.
Dosed and timed by your provider to match your goals and tolerance.
“It’s the same as Viagra.”
PT-141 works on brain arousal pathways, while PDE5 inhibitors like sildenafil work on blood flow — they solve different problems.
“It’s only for women.”
PT-141 is prescribed for both men and women experiencing low libido, with dosing adjusted accordingly.
“Any peptide source is fine as long as it’s cheap.”
Sourcing and dosing accuracy matter significantly with peptide therapy — that’s why it’s compounded and monitored by licensed pharmacies.
A questionnaire and health history establish whether PT-141 is appropriate for you.
Your provider sets an initial subcutaneous dose and timing relative to planned intimacy.
Check in with your provider to adjust dose or frequency based on your response.
30% OFF FOR LIFE.
to receive ongoing discounts.